Neurology and Neurosurgery - Global Neurology Academy

289-304 of 525

Challenges in DMD: Understanding the Height Factor
Challenges in DMD: Understanding the Height Factor
NeuroFrontiers
Challenges in DMD: Understanding the Height Factor
Schizophrenia Care: Improving Social Cognition and Motivation
Schizophrenia Care: Improving Social Cognition and Motivation
On the Frontlines of Schizophrenia
Schizophrenia Care: Improving Social Cognition and Motivation
Michael Green, PhD
- Michael Green, PhD
The Evolving gMG Treatment Landscape
The Evolving gMG Treatment Landscape
NeuroFrontiers
The Evolving gMG Treatment Landscape
Henry Kaminski, MD
- Henry Kaminski, MD
FcRn Inhibitors: A Potential New Targeted Therapy Option
FcRn Inhibitors: A Potential New Targeted Therapy Option
NeuroFrontiers
FcRn Inhibitors: A Potential New Targeted Therapy Option
Nicholas J. Silvestri, MD
- Nicholas J. Silvestri, MD
Unseen Struggles: Impacts of Homelessness on Women with Schizophrenia
Unseen Struggles: Impacts of Homelessness on Women with Schizophrenia
NeuroFrontiers
Unseen Struggles: Impacts of Homelessness on Women with Schizophrenia
Examining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
Examining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
NeuroFrontiers
Examining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
NeuroFrontiers
NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
NeuroFrontiers
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
Thomas Karikari, PhD
- Thomas Karikari, PhD
Preventing Alzheimer’s Disease Through Lifestyle Interventions
Preventing Alzheimer’s Disease Through Lifestyle Interventions
NeuroFrontiers
Preventing Alzheimer’s Disease Through Lifestyle Interventions
Michele Longo, MD
- Michele Longo, MD
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
NeuroFrontiers
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
Michele Longo, MD
- Michele Longo, MD
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
NeuroFrontiers
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
Robert Walker, PharmD; Deanna L. Kelly, PharmD, BCPP
- Robert Walker, PharmD
- Deanna L. Kelly, PharmD, BCPP
Advancing Schizophrenia Care: Challenges and Promising New Therapies
Advancing Schizophrenia Care: Challenges and Promising New Therapies
NeuroFrontiers
Advancing Schizophrenia Care: Challenges and Promising New Therapies
Charles Turck, PharmD, BCPS, BCCCP; Andrew J. Cutler, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Andrew J. Cutler, MD
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
NeuroFrontiers
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
Clifford Jack Jr., MD
- Clifford Jack Jr., MD
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
NeuroFrontiers
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
Clifford Jack Jr., MD
- Clifford Jack Jr., MD
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
NeuroFrontiers
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
Ashley Baker, MSN, PMHNP; Suzanne E. Schindler, MD, PhD
- Ashley Baker, MSN, PMHNP
- Suzanne E. Schindler, MD, PhD
Diagnosing Myasthenia Gravis: The Impact of Social Media
Diagnosing Myasthenia Gravis: The Impact of Social Media
Clinician's Roundtable
Diagnosing Myasthenia Gravis: The Impact of Social Media
Ashley Baker, MSN, PMHNP; Vishnu Pandurangadu, MD/MBA, FACEP
- Ashley Baker, MSN, PMHNP
- Vishnu Pandurangadu, MD/MBA, FACEP
- Pritikanta Paul, MD

19/11